NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc., (NASDAQ: BIOC), a global provider of clinical trial management services, will attend and speak at key industry conferences throughout the third and fourth quarters of 2011. Key BioClinica experts will provide insights into current industry topics and trends, as well as present the company’s expanded suite of technology capabilities and offerings.
Jim Dorsey, Vice President of Marketing for BioClinica said, “Our rapid technology evolution has greatly increased the scope and depth of BioClinica’s offerings. Participating in these upcoming events and showcasing our portfolio of new products enables clinical professionals to gain direct knowledge about these developments and better understand how our solutions might apply to their challenges.”
These events include:
2011 SCDM Annual Conference
September 11-14, 2011
Baltimore
Marriott Waterfront
Baltimore, MD
Booth # 401
The SCDM (Society for Clinical Data Management) Annual Conference is the world's largest education event for clinical data managers and related professionals, attracting approximately 650 attendees from across North America and around the world. BioClinica will be the Diamond Sponsor of this event and will showcase its eClinical Services.
ACRP’s NY Metropolitan Chapter Fall Symposium
September
16, 2011
Yale Club of NY
New York, NY
Jonathan Andrus, Vice President of Data Management and Quality, will speak on “Electronic Data Capture Systems – What is going on today and tomorrow?” on September 16 at 8:30 a.m., and will chair a session on: “Compliance and the Digital Age” in the afternoon. BioClinica will also demonstrate its efficient and cost-effective suite of clinical trial solutions at the Association of American Clinical Research Professionals Chapter Fall Symposium.
Outsourcing in Clinical Trials Northeast
September 28-29,
2011
The Boston Park Plaza Hotel & Towers
Boston, MA
Booth
# 24
Outsourcing in Clinical Trials Northeast brings together major pharma and biotech manufacturers to debate potential solutions to complex challenges. As the industry struggles to meet the challenges associated with a difficult economic climate, making the best use of available resources is now more important than ever before. As a leading provider of outsourced clinical trial services, BioClinica will demonstrate its efficient and cost-effective suite of clinical trial solutions and imaging solutions.
3rd CROss Alliance Summit
Quality of Data in Clinical
Development
October 6-7, 2011
Grand Hotel Eden
Lugano,
Switzerland
The Third CROss Summit will pull together the experience of industry and contract research organizations in the entire spectrum of clinical drug development (from drug production to overall project evaluation) focusing on the application of quality systems with the view to increase the accessibility of such experience and stimulate its widest use. BioClinica’s Jonathan Andrus, Vice President of Data Management and Quality, will present on October 7 at 11:15 a.m. in a session titled, “EDC-Compliance and validation considerations – A case for common sense.”
DIA 5th Annual Clinical Forum
October
10-11, 2011
Congress Center Basel
Basel,
Switzerland
The DIA (Drug Industry Association) 5th Annual Clinical Forum brings together industry-leading thinking and practices across the key disciplines of data management, clinical operations, drug safety and medical communication as they relate to the practical and operational aspects of drug development. Jonathan Andrus, BioClinica’s Vice President of Data Management and Quality, will speak about “The Revolving World of eClinical” on Monday, October 10 and 2:00 p.m. The session will discuss the effects resulting from eClinical systems’ replacement of traditional paper systems for collecting data and will explore some of the areas where the industry still struggles with amazingly persistent relics of paper past.
CDISC North American Interchange
October 12-13, 2011
Renaissance
Harborplace Hotel
Baltimore, MD
Jonathan Andrus, Vice President of Data Management and Quality, BioClinica, will chair the interactive session “eSource and Healthcare Link,” which will take place at on Thursday, October 13 from 10:30 a.m. to 12:00 p.m. with a panel that includes representatives from the Hamamatsu University School of Medicine, CMIC, Oracle and Florida Hospital MIS. CDISC is the Clinical Data Interchange Standards Consortium, the global, open, multidisciplinary, non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data and metadata.
Clinical Trial Supply East Coast 2011
October 19-20, 2011
Hilton
Philadelphia City Avenue
Philadelphia, PA
Reid Tonik, Director of Clinical Supply Chain Optimization, will present "Trends, Benefits and Practices 2011: Survey Results about Clinical Supply Chain Forecasting" on October 19 at 10:00 a.m. During this presentation he will discuss the highlights of a survey recently conducted by BioClinica and Paragon Solutions to establish industry benchmarks for managing clinical trial supplies. BioClinica will also demonstrate its Optimizer clinical supply simulation solution.
CBI’s Interactive Response Technologies for Clinical Trials
November
14-15, 2011
Embassy Suites Philadelphia Airport
Philadelphia,
PA
Ed Tourtellotte, Vice President, Product Innovation, will present “From the Dark Ages to the Present Day – Clinical IVR and IWR” on November 14 at 1:15 p.m. During this presentation he will examine the IVR value case and subsequent wide spread adoption. He will also discuss and identify solutions for key challenges, including scalability and speed. BioClinica will also showcase its Trident interactive web response system.
10th Annual Partnerships in Clinical Trials
November
15-18, 2011
Centre de Congrès, Lyon, France
Booth
# 325
The 10th Annual Partnerships in Clinical Trials is Europe's largest and most productive networking opportunity for clinical development outsourcing professionals. This conference brings together the most innovative thinkers in clinical development outsourcing from sponsors, CROs and other service providers. BioClinica will demonstrate its efficient and cost-effective suite of clinical trial solutions and imaging solutions.
Follow BioClinica and interact with conference speakers on the Trial Blazers blog at http://info.bioclinica.com/blog, and on twitter at http://twitter.com/bioclinica.
About BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management solutions. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management and clinical supply chain design and optimization solutions. BioClinica solutions maximize efficiency and manageability throughout all phases of the clinical trial process. With over 20 years of experience and more than 2,000 successful trials to date, BioClinica has supported the clinical development of many new medicines from early phase trials through final approval. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide eClinical and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com
Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company’s statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the consummation and the successful integration of current and proposed acquisitions, the timing of projects due to the variability in size, scope and duration of projects, estimates and guidance made by management with respect to the Company’s financial results, backlog, critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company’s control. The factors discussed herein and expressed from time to time in the Company’s filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstance. You should review the Company’s filings, especially risk factors contained in the Form 10-K and the recent Form 10-Q.